成都先导：两募集资金投资项目延期至2028年3月

Core Viewpoint - Chengdu XianDao announced the postponement of two major projects related to new molecular design and drug research center construction, now expected to be completed by March 2028 instead of December 2025 [1] Group 1: Project Details - The new molecular design and application platform project has an accumulated investment of 238 million yuan, with a progress rate of 47.84% [1] - The new drug research center construction project has an accumulated investment of 58 million yuan, with a progress rate of 35.88% [1] - Major construction for both projects has been completed, with the postponement attributed to project complexity and the need for comprehensive evaluations [1] Group 2: Impact and Approval - The postponement is not expected to adversely affect the company's normal operations [1] - The sponsoring institution has no objections to the decision regarding the project delays [1]